Pharmacological treatment of unipolar depression.

作者: Ian M. Anderson

DOI: 10.1007/7854_2012_208

关键词:

摘要: Antidepressants were first developed serendipitously 60 years ago and gave rise to the monoamine hypothesis of depression antidepressant action which has persisted in various forms ever since. Although we have made huge strides our understanding pharmacology antidepressants, neuroscience depression, current antidepressants changed little since original drugs. In this chapter I review some controversies use drugs including whether they actually work, then go on describe state clinical looking both at principles practice treatment reviewing evidence for efficacy, tolerability safety acute sequenced treatments. finally briefly consider future directions aspiration developing more effective antidepressants.

参考文章(97)
Sheldon H. Preskorn, CNS drug development: part III: future directions. Journal of Psychiatric Practice. ,vol. 17, pp. 49- 52 ,(2011) , 10.1097/01.PRA.0000393844.48593.82
Early Nonresponse to Fluoxetine as a Predictor of Poor 8-Week Outcome American Journal of Psychiatry. ,vol. 152, pp. 1500- 1503 ,(1995) , 10.1176/AJP.152.10.1500
M. Adli, Ch. Baethge, A. Heinz, N. Langlitz, M. Bauer, Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. European Archives of Psychiatry and Clinical Neuroscience. ,vol. 255, pp. 387- 400 ,(2005) , 10.1007/S00406-005-0579-5
Laura A. Pratt, Antidepressant use in persons aged 12 and over: United States, 2005-2008 NCHS data brief. ,vol. 76, pp. 1- 8 ,(2011)
Richard L. Rudolph, Louis F. Fabre, John P. Feighner, Karl Rickels, Richard Entsuah, Albert T. Derivan, A Randomized, Placebo-Controlled, Dose-Response Trial of Venlafaxine Hydrochloride in the Treatment of Major Depression The Journal of Clinical Psychiatry. ,vol. 59, pp. 116- 122 ,(1998) , 10.4088/JCP.V59N0305
Roland Mergl, Verena Henkel, Antje-Kathrin Allgaier, Dietmar Kramer, Martin Hautzinger, Ralf Kohnen, James Coyne, Ulrich Hegerl, Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm Psychotherapy and Psychosomatics. ,vol. 80, pp. 39- 47 ,(2011) , 10.1159/000318772
Alan J. Gelenberg, Michael E. Thase, Roger E. Meyer, Frederick K. Goodwin, Martin M. Katz, Helena Chmura Kraemer, William Z. Potter, Richard C. Shelton, Maurizio Fava, Arif Khan, Madhukar H. Trivedi, Philip T. Ninan, John J. Mann, Susan Bergeson, Jean Endicott, Jean Endicott, James H. Kocsis, Andrew C. Leon, Husseini K. Manji, Jerrold F. Rosenbaum, The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. The Journal of Clinical Psychiatry. ,vol. 69, pp. 1513- 1528 ,(2008) , 10.4088/JCP.V69N1001
Alessandro Serretti, Alberto Chiesa, Treatment-Emergent Sexual Dysfunction Related to Antidepressants Journal of Clinical Psychopharmacology. ,vol. 29, pp. 259- 266 ,(2009) , 10.1097/JCP.0B013E3181A5233F
John Curry, Susan Silva, Paul Rohde, Golda Ginsburg, Christopher Kratochvil, Anne Simons, Jerry Kirchner, Diane May, Betsy Kennard, Taryn Mayes, Norah Feeny, Anne Marie Albano, Sarah Lavanier, Mark Reinecke, Rachel Jacobs, Emily Becker-Weidman, Elizabeth Weller, Graham Emslie, John Walkup, Elizabeth Kastelic, Barbara Burns, Karen Wells, John March, Recovery and Recurrence Following Treatment for Adolescent Major Depression Archives of General Psychiatry. ,vol. 68, pp. 263- 270 ,(2011) , 10.1001/ARCHGENPSYCHIATRY.2010.150